PT Phapros Tbk (ISX:PEHA) FFO


ISX:PEHA PT Phapros Tbk ISX:PEHA
72 GF Score
Price Rp246.00
GF Value Rp384.86
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PT Phapros Tbk FFO?

FFO (Funds from operations) only applies to REITs.

ISX:PEHA
72GF Score
PT Phapros Tbk ISX:PEHA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Phapros Tbk (ISX:PEHA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Phapros Tbk stock appears to be undervalued. The current stock price of Rp246.00 is trading 36.1% below its estimated GF Value™ of Rp384.86. GuruFocus considers PT Phapros Tbk to be Possible Value Trap.

Key valuation signals for ISX:PEHA:

  • FFO:
  • GF Value™: Rp384.86 vs. price of Rp246.00 (36.1% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the ISX:PEHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Phapros Tbk Business Description

Address Jl. Dr. Ide Anak Agung Gde Agung, Menara Rajawali Lt. 17, Kuningan, Jakarta Selatan, Jakarta, IDN, 12950
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments. It derives maximum revenue from OGB segment.
72GF Score

Get the complete analysis for ISX:PEHA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp246.00
Price
Rp384.86
GF Value